Terms: = Liver cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4
906 results:
1. Development of Highly Potent and Selective Covalent FGFR4 Inhibitors Based on S
Schwarz M; Kurkunov M; Wittlinger F; Rudalska R; Wang G; Schwalm MP; Rasch A; Wagner B; Laufer SA; Knapp S; Dauch D; Gehringer M
J Med Chem; 2024 Apr; 67(8):6549-6569. PubMed ID: 38604131
[TBL] [Abstract] [Full Text] [Related]
2. Identification of ASF1A and HJURP by global H3-H4 histone chaperone analysis as a prognostic two-gene model in hepatocellular carcinoma.
Liu Y; Liu S; Jing R; Li C; Guo Y; Cai Z; Xi P; Dai P; Jia L; Zhu H; Zhang X
Sci Rep; 2024 Apr; 14(1):7666. PubMed ID: 38561384
[TBL] [Abstract] [Full Text] [Related]
3. Circular RNA circTATDN3 promotes the Warburg effect and proliferation in colorectal cancer.
Lin J; Zhong W; Lyu Z; Peng J; Rong Y; Zeng K; Lai J; Wu D; Wang J; Li Y; Zheng J; Zhang J; Pan Z
Cancer Lett; 2024 May; 589():216825. PubMed ID: 38548218
[TBL] [Abstract] [Full Text] [Related]
4. Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases.
Li CMY; Briggs MT; Lee YR; Tin T; Young C; Pierides J; Kaur G; Drew P; Maddern GJ; Hoffmann P; Klingler-Hoffmann M; Fenix K
Clin Exp Med; 2024 Mar; 24(1):53. PubMed ID: 38492056
[TBL] [Abstract] [Full Text] [Related]
5. Transcriptomic screening of novel targets of sericin in human hepatocellular carcinoma cells.
Jantaravinid J; Tirawanchai N; Ampawong S; Kengkoom K; Somkasetrin A; Nakhonsri V; Aramwit P
Sci Rep; 2024 Mar; 14(1):5455. PubMed ID: 38443583
[TBL] [Abstract] [Full Text] [Related]
6. Design, synthesis, and biological evaluation of selective covalent inhibitors of FGFR4.
Chen X; Li H; Lin Q; Dai S; Qu L; Guo M; Zhang L; Liao J; Wei H; Xu G; Jiang L; Chen Y
Eur J Med Chem; 2024 Mar; 268():116281. PubMed ID: 38432058
[TBL] [Abstract] [Full Text] [Related]
7. OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway.
Ci M; Zhao G; Li C; Liu R; Hu X; Pan J; Shen Y; Zhang G; Li Y; Zhang L; Liang P; Cui H
Cell Death Dis; 2024 Mar; 15(3):179. PubMed ID: 38429268
[TBL] [Abstract] [Full Text] [Related]
8. Histone H3Y99sulf regulates hepatocellular carcinoma responding to hypoxia.
Yin S; Yu W; Zhou R; Zeng X; Jiang L; Wang Y; Guo D; Tong F; He L; Zhao J; Wang Y
J Biol Chem; 2024 Mar; 300(3):105721. PubMed ID: 38311175
[TBL] [Abstract] [Full Text] [Related]
9. Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma.
Demir S; Razizadeh N; Indersie E; Branchereau S; Cairo S; Kappler R
Hepatol Commun; 2024 Feb; 8(2):. PubMed ID: 38285887
[TBL] [Abstract] [Full Text] [Related]
10. Mutation status of the KMT2 family associated with immune checkpoint inhibitors (ICIs) therapy and implicating diverse tumor microenvironments.
Wang DX; Long JY; Li RZ; Zhang DL; Liu H; Liu J; Tian JC; Li H; Liu J; Zhao HT; Li T
Mol Cancer; 2024 Jan; 23(1):15. PubMed ID: 38225603
[TBL] [Abstract] [Full Text] [Related]
11. Targeting the FGF19-FGFR4 pathway for cholestatic, metabolic, and cancerous diseases.
Li X; Lu W; Kharitonenkov A; Luo Y
J Intern Med; 2024 Mar; 295(3):292-312. PubMed ID: 38212977
[TBL] [Abstract] [Full Text] [Related]
12. Heterogeneity-induced NGF-NGFR communication inefficiency promotes mitotic spindle disorganization in exhausted T cells through PREX1 suppression to impair the anti-tumor immunotherapy with PD-1 mAb in hepatocellular carcinoma.
Wang X; Yang T; Shi S; Xu C; Wang F; Dai D; Guan G; Zhang Y; Wang S; Wang J; Zhang B; Liu P; Bai X; Jin Y; Li X; Zhu C; Chen D; Xu Q; Guo Y
Cancer Med; 2024 Feb; 13(3):e6736. PubMed ID: 38204220
[TBL] [Abstract] [Full Text] [Related]
13. Identification of a Sonically Activated Degrader of Methionine Adenosyltransferase 2A by an
He H; Wang Z; Peng X; Qing L; Zhang Y; Fu S; Xu J; Li Y; Zhang S
J Med Chem; 2024 Jan; 67(1):543-554. PubMed ID: 38166392
[TBL] [Abstract] [Full Text] [Related]
14. Histone methyltransferase SUV420H1/KMT5B contributes to poor prognosis in hepatocellular carcinoma.
Kato H; Hayami S; Ueno M; Suzaki N; Nakamura M; Yoshimura T; Miyamoto A; Shigekawa Y; Okada KI; Miyazawa M; Kitahata Y; Ehata S; Hamamoto R; Yamaue H; Kawai M
Cancer Sci; 2024 Feb; 115(2):385-400. PubMed ID: 38082550
[TBL] [Abstract] [Full Text] [Related]
15. BAP18 acting as a novel peroxisome proliferator-activated receptor α co-regulator contributes to hepatocellular carcinoma progression.
Liu W; Wang S; Lin L; Zou R; Sun H; Zeng K; Wu Y; Li Y; Shigeaki K; Wang X; Wang C; Zhao Y
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166974. PubMed ID: 38042310
[TBL] [Abstract] [Full Text] [Related]
16. (S)-3-(3-Fluoro-4-Methoxybenzyl)-5,6,7-Trimethoxychroman-4-One Suppresses the Proliferation of Huh7 Cells by Up-regulating P21 and Inducing G
Yoon H; Lee J; Kwon S; Seo SY; Cho S
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):754-762. PubMed ID: 38035711
[TBL] [Abstract] [Full Text] [Related]
17. EZH2 is a key component of hepatoblastoma tumor cell growth.
Glaser K; Schepers EJ; Zwolshen HM; Lake CM; Timchenko NA; Karns RA; Cairo S; Geller JI; Tiao GM; Bondoc AJ
Pediatr Blood Cancer; 2024 Feb; 71(2):e30774. PubMed ID: 37990130
[TBL] [Abstract] [Full Text] [Related]
18. The Molecular, Immunologic, and Clinicodemographic Landscape of MYC-Amplified Advanced Prostate cancer.
Jin WH; Zhang L; Graf R; Raskina K; Tukachinsky H; Huang RSP; McGregor K; Alshalalfa M; Hougen HY; Khan A; Punnen S; Schrock AB; Venstrom J; Mahal BA
Clin Genitourin Cancer; 2024 Feb; 22(1):e163-e169.e1. PubMed ID: 37978032
[TBL] [Abstract] [Full Text] [Related]
19. Insight into the design of FGFR4 selective inhibitors in cancer therapy: Prospects and challenges.
Chen X; Huang Y; Chen B; Liu H; Cai Y; Yang Y
Eur J Med Chem; 2024 Jan; 263():115947. PubMed ID: 37976704
[TBL] [Abstract] [Full Text] [Related]
20. Fusing Positive and Negative CT Contrast Nanoagent for the Sensitive Detection of Hepatoma.
Meng X; Gao J; Sun Y; Duan F; Chen B; Lv G; Li H; Jiang X; Wu Y; Zhang J; Fang X; Yao Z; Zuo C; Bu W
Adv Sci (Weinh); 2023 Dec; 10(34):e2304668. PubMed ID: 37870166
[TBL] [Abstract] [Full Text] [Related]
[Next]
